Biomedix Incubator Ltd
Biomedix Incubator Ltd is a venture capital firm and accelerator specializing in start-up and incubation investments. The firm seeks to invest in life science sector including medical equipment, green technology, software, and alternative energy. Biomedix Incubator Ltd. was founded in 2000 and is based in Ramat Gan, Israel with an additional office in New York, New York.
Biomedix Incubator Ltd (BMDX) - Total Assets
Latest total assets as of June 2017: ILA5.77 Million ILA
Based on the latest financial reports, Biomedix Incubator Ltd (BMDX) holds total assets worth ILA5.77 Million ILA as of June 2017.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Biomedix Incubator Ltd - Total Assets Trend (2013–2016)
This chart illustrates how Biomedix Incubator Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Biomedix Incubator Ltd - Asset Composition Analysis
Current Asset Composition (December 2016)
Biomedix Incubator Ltd's total assets of ILA5.77 Million consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 56.9% |
| Accounts Receivable | ILA6.00K | 0.1% |
| Inventory | ILA0.00 | 0.0% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2013–2016)
This chart illustrates how Biomedix Incubator Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Biomedix Incubator Ltd's current assets represent 100.0% of total assets in 2016, an increase from 100.0% in 2013.
- Cash Position: Cash and equivalents constituted 56.9% of total assets in 2016, up from 35.0% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2013.
- Asset Diversification: The largest asset category is accounts receivable at 0.1% of total assets.
Biomedix Incubator Ltd Competitors by Total Assets
Key competitors of Biomedix Incubator Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
Big Tech 50 R&D-Limited Partnership
TA:BIGT
|
Israel | ILA14.08 Million |
Biomedix Incubator Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Biomedix Incubator Ltd generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Biomedix Incubator Ltd is currently not profitable relative to its asset base.
Biomedix Incubator Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 30.06 | 26.50 | 26.50 |
| Quick Ratio | 30.06 | 26.50 | 26.50 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA5.58 Million | ILA 6.58 Million | ILA 6.58 Million |
Biomedix Incubator Ltd - Advanced Valuation Insights
This section examines the relationship between Biomedix Incubator Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -18.6% |
| Total Assets | ILA6.92 Million |
| Market Capitalization | $119.97K USD |
Valuation Analysis
Below Book Valuation: The market values Biomedix Incubator Ltd's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Biomedix Incubator Ltd's assets decreased by 18.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Biomedix Incubator Ltd (2013–2016)
The table below shows the annual total assets of Biomedix Incubator Ltd from 2013 to 2016.
| Year | Total Assets | Change |
|---|---|---|
| 2016-12-31 | ILA6.92 Million | -18.61% |
| 2015-12-31 | ILA8.50 Million | -34.39% |
| 2014-12-31 | ILA12.95 Million | -42.87% |
| 2013-12-31 | ILA22.67 Million | -- |